“Sustained seroprevalence of SARS-CoV-2 antibodies one year after infection: one of the first COVID-19 cluster cases in Bosnia and Herzegovina” (2022) Biomolecules and Biomedicine, 22(1), pp. 147–152. doi:10.17305/bjbms.2021.6340.